Hamilton Morris interviews Michael Pollan

Michael Pollan discusses his investigative approach to the psychedelic renaissance and the complex societal landscape surrounding these substances. He highlights how his initial naivete and eventual engagement with clinical research transformed his perception of psychedelics, moving from fear-based misinformation to an appreciation of their therapeutic potential. By examining the history of the war on drugs and the cultural shifts surrounding plant-based medicines, he contextualizes the current excitement within the medical establishment. The conversation explores the ethical complexities of bringing these substances into mainstream medicine. Pollan weighs the benefits of clinical approval and pharmaceutical development against risks such as aggressive corporate marketing and potential loss of access for some demographics. He contrasts these structured therapy models with communal uses, expressing concern about the risks of over-medicalizing and over-regulating these experiences while acknowledging the promise of psychedelic-assisted psychotherapy for conditions like depression and addiction.